,,ii #aagth ,,congress #b;d ,session ,s4 #cdgh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,january #aa 7legislative day1 ,january #aj71 #bjbb,mr4 ,casey 7for himself1 ,mr4 ,cassidy1 and ,mr4 ,murphy7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to provide for the designation of biological products as qualified infectious disease products4 #a4 ,short title ,this ,act may be cited as the ,generating ,antibiotic ,incentives ,now ,through ,opening ,opportunities to ,leverage ,science ,act of #bjbb or the ,,gain ,,tools ,act of #bjbb4 #b4 ,expanding qualified infectious disease products to include biological products 7a7 ,in general ,section #eje;,e of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee;f7 is amended-- 7#a7 in subsection 7c7-- 7,a7 in paragraph 7#b71 by striking 2 or and inserting 22 7,b7 in paragraph 7#c71 by striking the period and inserting 2 or2 and 7,c7 by adding at the end the following3 7#d7 an application pursuant to section #cea7;a7 of the ,public ,health ,service ,act4 2 7#b7 in subsection 7d77#a71 by inserting of this ,act or section #cea7;a7 of the ,public ,health ,service ,act after section #eje7;b72 and 7#c7 by amending subsection 7g7 to read as follows3 7g7 ,qualified infectious disease product ,the term qualified infectious disease product means a drug or biological product for human use that-- 7#a7 is-- 7,a7 an antibacterial or antifungal drug2 or 7,b7 a biological product that acts directly on bacteria or fungi or on substances produced by such bacteria or fungi2 and 7#b7 is intended to treat a serious or life-threatening infection1 including such an infection caused by-- 7,a7 an antibacterial or antifungal resistant pathogen1 including novel or emerging infectious pathogens2 or 7,b7 qualifying pathogens listed by the ,secretary under subsection 7f74 4 7b7 ,priority review ,section #ebd;,a7a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfjn-#a7;a77 is amended by inserting of this ,act1 or section #cea7;a7 of the ,public ,health ,service ,act1 that requires clinical data 7other than bioavailability studies7 to demonstrate safety or effectiveness before the period4